Nasdaq:US$13.20 (-0.22) | HKEX:HK$20.25 (-0.45) | AIM:£2.06 (-0.12)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases | 8 Apr 2024

Preclinical characterization of HMPL-295, a potent and selective ERK1/2 inhibitor